Psilocybin
Breaking News: San Francisco Decriminalizes Psychedelics
The article Breaking News: San Francisco Decriminalizes Psychedelics was originally published on Microdose.
The city of San Francisco has joined cities…
The article Breaking News: San Francisco Decriminalizes Psychedelics was originally published on Microdose.
The city of San Francisco has joined cities like Detroit and Seattle as the latest to decriminalize psychedelics.
Sponsored by Supervisors Dean Preston (D) and Hillary Ronen (D), lawmakers have unanimously approved the decriminalization of psychedelics like psilocybin and ayahuasca. The measure doesn’t officially change any laws, instead requesting that police deprioritize psychedelics as being among “the lowest priority” for law enforcement. It also requests that the city redirects its resources…
“…City resources not be used for any investigation, detention, arrest, or prosecution arising out of alleged violations of state and federal law regarding the use of Entheogenic Plants listed on the Federally Controlled Substances Schedule 1 list.”
We are so thrilled to announce that our resolution to decriminalize plants medicines and psilocybin mushrooms passed in San Francisco. May compassion and love prevail here and everywhere! Thank you @DeanPreston and @HillaryRonen for the bravery and intelligence! pic.twitter.com/q3ZANaRQry
— Decrim SF (@DecrimSf) September 7, 2022
For more on this check out Seattle Largest U.S. City to Decriminalize Psychedelics and British Columbia Decriminalizes Drug Possession
psilocybin ayahuasca laws decriminalization psychedelics
-
Psychedelics1 week agoMindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
-
Psychedelics1 week agoReunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings
-
Psychedelics1 week agoCompass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
-
Psychedelics1 week ago
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
-
Ketamine1 week ago
What marijuana reclassification could mean for health treatments
-
Psychedelics1 week ago
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
-
Psilocybin5 days agoThe Psychedelic Scene in Oaxaca, Mexico
-
Psychedelics1 week ago
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings
